Clinical Trial Update: Mirabegron And Ureteral Stent-related Pain (MAP) Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for mirabegron addressing ureteral stent-related pain in nephrolithiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Unity Health Toronto | Conditions: Nephrolithiasis | Phase 3 | Status: UNKNOWN